News


CLCC to attend LSI Asia 2025
Thang Vo-Ta
Co-Founder & CEO

Always excited to return home to Singapore 🇸🇬 – and especially looking forward to attend LSIAsia25 next month, LSI’s first Asian summit! Looking forward to a packed agenda of meetings and reconnecting with contacts & collaborators, both old and new. ✊

Scheilly Tsilova PhD joins as Senior Pharmaceutical Scientist

We’re delighted to welcome Scheilly Tsilova, Ph.D to the Calla Lily Clinical Care team as our new Senior Pharmaceutical Scientist. 🥼 For the past two years, Scheilly has been instrumental in advancing our Callavid® vaginal drug delivery technology while pursuing her PhD at UCL, with a focus on polymer-based drug delivery systems. Her deep technical …

Latest Recurrent Pregnancy Loss guidelines at ACOG
Thang Vo-Ta
Co-Founder & CEO

One of the highlights of attending the latest annual ACOG Clinical & Scientific meeting was joining a packed auditorium to hear Dr Ruth Lathi’s compelling lecture, “New Guidelines, New Hope for Recurrent Pregnancy Loss.” 📖 Dr. Lathi, the Director of the Multi-Specialty Recurrent Pregnancy Loss Program and Professor of Obstetrics and Gynecology at Stanford University …

WAM Forum Learnings
Dr Lara Zibners
Co-Founder & Chairman

3 things I learned at the WAM Forum luncheon in Las Vegas! I was so delighted to be invited to attend the Women’s Alzheimer’s Movement forum networking breakfast and luncheon yesterday. Such an incredible group of people brought together to find collaboration and solutions for women’s health. Our bodies are pretty intertwined. Brain health is …

ACOG in Minneapolis
Thang Vo-Ta
Co-Founder & CEO

Spending time in Minneapolis for the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting was even better than I had hoped. Besides the constant engagement with passionate American OBGYNs (so many of which are excited to hear about our Callavid® drug delivery technology) – it was superb to connect with other …

HLTH Europe Startup Finalist

Delighted to be named a 2025 finalist in the HLTH Europe Startup Pitch, sponsored by Haleon! Honoured to share the stage with some of the most innovative healthtech startups in Europe. See you in Amsterdam. 🇳🇱

Naomi Aduroja joins as a Roivant Social Ventures Global Access Fellow

💥 A warm welcome to Naomi Aduroja who joins us as a Roivant Social Ventures Global Access Fellow this summer. Currently preparing for her third year in the prestigious PharmD program at UNC Eshelman School of Pharmacy – we’re delighted to have Naomi support various R&D projects leaning on her experience including from across pharmacy …

ACOG Clinical & Scientific Meeting in Minneapolis

We’re delighted to be in Minneapolis for the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting. From May 16th-18th, we’ll be ready to connect, collaborate, and showcase our Callavid® vaginal drug delivery innovation at the largest meeting of obstetricians and gynecologists in the US. This is an exciting opportunity to discuss …

Amy Coulson joins the Vaginal Microbiome team

We’re delighted to welcome Amy Coulson to CLCC in advance of starting her Ph.D. journey at Queen Mary University of London. Over the next 4 years she’ll be working with our team and QMUL’s Centre for Doctoral Training in Next Generation Organ on a Chip Technology (COaCT) to develop a vaginal organ-on-a-chip to grasp successful …

Discover CLCC’s B Corp Impact Report

We believe that true success in business must be measured not just by commercial milestones, but by the positive impact we create. To us, being a B Corp is more than a certification – it’s a daily commitment to balancing people, planet, profit, and purpose. B Lab’s rigorous standards provide a clear framework for accountability …